RERE enters Thursday's investor event with the best of both worlds and one unresolved question.
Q1 results delivered a clean beat — adjusted EPS of $0.13 nearly doubled the $0.07 consensus, and revenue of $893M cleared the $860M bar. The stock jumped 11.6% on the day and closed the week at $5.02, up 8.9%, recovering almost all of its month-long losses. The one wrinkle is Q2 guidance: management pencilled in $900.9M–$915.3M against a Street estimate of $927.2M, a midpoint miss of roughly 1.3%. That gap is the primary tension now that the earnings numbers are public.
The borrow market offers no hint of bearish conviction building around that guidance miss. Availability is exceptionally loose — roughly 49 shares remain available to borrow for every one already borrowed, and that ratio has widened sharply over the past week, up 83% from already-comfortable levels. Cost to borrow has drifted lower too, settling near 0.45% after running above 0.55% for much of April. Short interest at 1.4% of the free float is both low and barely moving, edging up just 1.2% on the week. The ORTEX short score has dropped from 35.8 to 33.9 over the past ten days — moving in the opposite direction from what you'd expect if the guidance gap were prompting fresh shorts. Positioning, in short, remains unconvinced by the bear case.
Valuation reinforces why the stock has defenders. RERE trades at a trailing P/E of 9.8x and an EV/EBITDA of 8.2x — lean multiples for a profitable recommerce platform that has consistently beaten consensus estimates. EPS surprise ranks in the 97th percentile of the universe, and EPS momentum is strong at the 85th percentile over 90 days. The only soft spot in the factor profile is forward EPS growth expectation, which ranks just 21st percentile — meaning the Street's optimism about RERE is rooted more in what it's already earning than what analysts expect it to earn next year.
Ownership adds an interesting structural note. JD.com holds 33.6% of shares, making ATRenew effectively a JD-linked vehicle for many international investors. CEO Xuefeng Chen added 9.1 million shares in March, lifting his stake to 11.8% — a meaningful addition that aligns management directly with the guidance question now in front of the market. Tiger Global and T. Rowe Price both hold positions, and T. Rowe added 326,000 shares in Q1. Wellington trimmed by 777,000 shares over the same period, and Morgan Stanley cut its position by nearly 950,000 — a mild divergence between growth-oriented holders and institutional desks taking chips off the table.
The last earnings print that carried price-reaction data — the March 11 release — produced a 9.8% one-day drop and a 13.2% five-day decline. That prior reaction came without the kind of clean beat-and-guide dynamic now in play, so direct comparison is limited. What is comparable is the structure: a company with thin short interest, loose borrow conditions, and a valuation that prices in neither disaster nor transformation. When the guidance gap is the only substantive complaint after an otherwise strong quarter, Thursday's session becomes less about the numbers themselves and more about whether management's framing of the Q2 outlook is enough to close the distance between their midpoint and the Street's prior estimate.
See the live data behind this article on ORTEX.
Open RERE on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
